Precision BioSciences (DTIL) News Today → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free DTIL Stock Alerts $11.62 +0.12 (+1.04%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 5:21 PM | markets.businessinsider.comMaintaining Hold on Precision BioSciences Pending Clinical Data and Strategic ReassessmentsMay 14 at 2:19 AM | markets.businessinsider.comPrecision BioSciences Reports Profit From Cont. Ops. In Q1May 14 at 2:19 AM | markets.businessinsider.comBuy Rating Affirmed for Precision BioSciences on Advancing Gene Editing Pipeline and Strong FinancialsMay 13 at 9:18 PM | markets.businessinsider.comQuarterly Results Takes Precision BioSciences HigherMay 13 at 7:00 AM | businesswire.comPrecision BioSciences Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 11, 2024 | americanbankingnews.comPrecision BioSciences (DTIL) to Release Quarterly Earnings on MondayMay 8, 2024 | marketbeat.comPrecision BioSciences (DTIL) Scheduled to Post Earnings on MondayPrecision BioSciences (NASDAQ:DTIL) will be releasing earnings before the market opens on Monday, May 13, Zacks reports.May 8, 2024 | finance.yahoo.comPrecision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private PlacementMay 7, 2024 | finance.yahoo.comPrecision BioSciences to Report First Quarter Results on May 13, 2024May 7, 2024 | markets.businessinsider.comWhy Precision BioSciences Is Rising In Pre-market?May 7, 2024 | finance.yahoo.comPrecision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) DeficiencyMay 7, 2024 | businesswire.comPrecision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) DeficiencyMay 5, 2024 | americanbankingnews.comMichael Amoroso Sells 1,526 Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) StockMay 4, 2024 | insidertrades.comPrecision BioSciences, Inc. (NASDAQ:DTIL) CEO Michael Amoroso Sells 1,526 SharesMay 3, 2024 | marketbeat.comInsider Selling: Precision BioSciences, Inc. (NASDAQ:DTIL) CEO Sells 1,526 Shares of StockPrecision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) CEO Michael Amoroso sold 1,526 shares of the business's stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $10.32, for a total transaction of $15,748.32. Following the completion of the sale, the chief executive officer now directly owns 13,772 shares of the company's stock, valued at approximately $142,127.04. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.May 1, 2024 | businesswire.comPrecision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024April 30, 2024 | marketbeat.comPrecision BioSciences (NASDAQ:DTIL) Receives New Coverage from Analysts at GuggenheimGuggenheim initiated coverage on Precision BioSciences in a research note on Tuesday. They set a "buy" rating and a $19.00 target price on the stock.April 26, 2024 | yahoo.comPrecision Air & Plumbing says if you need a new AC the time is NOWApril 18, 2024 | finanznachrichten.deMillennium Precision LLC Achieves ISO 13485 Certification: A Milestone Towards Excellence and Celebrating 20 Years of Continuous Growth and InnovationApril 17, 2024 | marketbeat.comPrecision BioSciences' (DTIL) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $60.00 price target on shares of Precision BioSciences in a research note on Wednesday.April 17, 2024 | msn.comPrecision BioSciences (DTIL) Price Target Decreased by 22.17% to 36.52April 16, 2024 | msn.comEli Lilly subsidiary, Precision Biosciences end gene therapy collaborationApril 11, 2024 | investing.comPrecision BioSciences Inc (DTIL)April 9, 2024 | yahoo.comPrecision Air & Plumbing offers tips on buying a new AC unit before summer hitsApril 9, 2024 | forbes.comPrecision Diagnostics Can Save Money In Healthcare: What’s Holding Them Back?April 2, 2024 | finance.yahoo.comWall Street Analysts Predict a 407.94% Upside in Precision BioSciences (DTIL): Here's What You Should KnowMarch 31, 2024 | marketbeat.comResearch Analysts Offer Predictions for Precision BioSciences, Inc.'s Q1 2025 Earnings (NASDAQ:DTIL)Precision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Analysts at HC Wainwright issued their Q1 2025 EPS estimates for Precision BioSciences in a research report issued to clients and investors on Thursday, March 28th. HC Wainwright analyst P. Trucchio anticipates that the company will post eMarch 29, 2024 | marketbeat.comPrecision BioSciences, Inc. Expected to Earn Q1 2025 Earnings of ($0.85) Per Share (NASDAQ:DTIL)Precision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Precision BioSciences in a report issued on Thursday, March 28th. HC Wainwright analyst P. Trucchio expects that the company will pMarch 28, 2024 | markets.businessinsider.comBuy Rating Affirmed for Precision BioSciences on Promising Gene Editing Prospects and Strong FinancialsMarch 28, 2024 | marketbeat.comPrecision BioSciences (NASDAQ:DTIL) PT Raised to $60.00HC Wainwright lifted their price objective on Precision BioSciences to $60.00 and gave the stock a "buy" rating in a research report on Thursday.March 27, 2024 | markets.businessinsider.comBuy Rating Affirmed for Precision BioSciences as Milestones in Gene Editing Technology LoomMarch 27, 2024 | investorplace.comDTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023March 27, 2024 | markets.businessinsider.comPrecision BioSciences Inc Q4 Loss decreases, but misses estimatesMarch 27, 2024 | businesswire.comPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business UpdateMarch 26, 2024 | benzinga.comEarnings Preview: Precision BioSciencesMarch 26, 2024 | msn.comPrecision BioSciences Q4 Earnings PreviewMarch 21, 2024 | marketbeat.comPrecision BioSciences (DTIL) Set to Announce Quarterly Earnings on WednesdayPrecision BioSciences (NASDAQ:DTIL) will be releasing earnings before the market opens on Wednesday, March 27, Zacks reports.March 20, 2024 | businesswire.comPrecision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024March 19, 2024 | baystreet.caPrecision BioSciences Flat on New Product DevelopmentMarch 19, 2024 | businesswire.comPrecision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial MyopathyMarch 18, 2024 | finance.yahoo.comDNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD SummitMarch 15, 2024 | yahoo.comFender teams up with Fornite to bring its Stratocaster and Precision Bass to the digital realmMarch 14, 2024 | bizjournals.comMachining company Thomas Precision sells vacant Union County facilityMarch 12, 2024 | msn.comThe Anova Precision Cooker Nano sous vide machine drops to a record low of $60March 7, 2024 | finance.yahoo.comPrecision BioSciences, Inc. (PBS0.F)March 6, 2024 | businesswire.comPrecision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC DeficiencyMarch 4, 2024 | bizjournals.comDurham gene editing firm raising $40M for Hepatitis B treatmentMarch 2, 2024 | investing.comPrecision BioSciences announces public stock offeringMarch 1, 2024 | marketwatch.comPrecision BioSciences Shares Slide Premarket After Stock OfferingMarch 1, 2024 | msn.comCardiff Oncology, DermTech, Precision Biosciences among healthcare movers Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address How to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs DTIL Media Mentions By Week DTIL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DTIL News Sentiment▼0.790.56▲Average Medical News Sentiment DTIL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DTIL Articles This Week▼103▲DTIL Articles Average Week Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Instil Bio News Atara Biotherapeutics News Elutia News Turnstone Biologics News Cognition Therapeutics News Ikena Oncology News Athira Pharma News Protalix BioTherapeutics News Genenta Science News Entera Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DTIL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
